Ledger.Open graph →

SEC Form D · filed August 9, 2024

Artax Biopharma, Inc

Offering

$8.0M

Sold

$6.0M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

CAMBRIDGE, MA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (23)

Maria W. Nichol · Cambridge, MAExec Raj W. Parekh · Cambridge, MADirector Gino M. Santini · Cambridge, MADirector Damia M. Tormo · Cambridge, MADirector Alan E. Walts · Cambridge, MADirector Andre W. Hoekema · Cambridge, MADirector Casper W. Breum · Cambridge, MADirector Scott Stout · El Segundo, CADirector Bonnie Gurry · New York, NYDirector Andre W. Hoekema · Cambridge, MADirector Ian Leaman · El Segundo, CADirector Drew Anwyll · Toronto, Ontario, CanadaDirector Edwin Kania · LOS ANGELES, CADirector Maria W. Nichol · Cambridge, MAExec Robert Armstrong · Heppner, ORExec · Director Arne Brock-Utne · Lafayette, CADirector David T. Lubner · Gaithersburg, MDDirector Sabri Murat Bicer · Palo Alto, CADirector Philip Fukushima · HONOLULU, HIDirector Craig Brede · Englewood, CODirector Larry Tiffany · Riverdale, MDDirector Michael Bucella · Miami, FLExec Robert Armstrong · Cambridge, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗